JP2015522049A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522049A5
JP2015522049A5 JP2015520915A JP2015520915A JP2015522049A5 JP 2015522049 A5 JP2015522049 A5 JP 2015522049A5 JP 2015520915 A JP2015520915 A JP 2015520915A JP 2015520915 A JP2015520915 A JP 2015520915A JP 2015522049 A5 JP2015522049 A5 JP 2015522049A5
Authority
JP
Japan
Prior art keywords
weight
formulation
amount
alcohol
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520915A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015522049A (ja
JP6259454B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/064123 external-priority patent/WO2014009241A1/en
Publication of JP2015522049A publication Critical patent/JP2015522049A/ja
Publication of JP2015522049A5 publication Critical patent/JP2015522049A5/ja
Application granted granted Critical
Publication of JP6259454B2 publication Critical patent/JP6259454B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520915A 2012-07-12 2013-07-04 ジクロフェナク製剤 Active JP6259454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12176115 2012-07-12
EP12176115.9 2012-07-12
PCT/EP2013/064123 WO2014009241A1 (en) 2012-07-12 2013-07-04 Diclofenac formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017182383A Division JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Publications (3)

Publication Number Publication Date
JP2015522049A JP2015522049A (ja) 2015-08-03
JP2015522049A5 true JP2015522049A5 (cg-RX-API-DMAC7.html) 2016-06-16
JP6259454B2 JP6259454B2 (ja) 2018-01-10

Family

ID=48741196

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015520915A Active JP6259454B2 (ja) 2012-07-12 2013-07-04 ジクロフェナク製剤
JP2017182383A Active JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017182383A Active JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Country Status (14)

Country Link
US (2) US9999590B2 (cg-RX-API-DMAC7.html)
EP (2) EP3275466A1 (cg-RX-API-DMAC7.html)
JP (2) JP6259454B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150030752A (cg-RX-API-DMAC7.html)
CN (1) CN104428003B (cg-RX-API-DMAC7.html)
AU (1) AU2013289403B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015000329A2 (cg-RX-API-DMAC7.html)
CA (1) CA2878784A1 (cg-RX-API-DMAC7.html)
HK (1) HK1204973A1 (cg-RX-API-DMAC7.html)
IL (1) IL236304A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015000541A (cg-RX-API-DMAC7.html)
NZ (1) NZ702967A (cg-RX-API-DMAC7.html)
RU (1) RU2014152445A (cg-RX-API-DMAC7.html)
WO (1) WO2014009241A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10813897B2 (en) * 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
AU2013289403B2 (en) * 2012-07-12 2017-05-11 Ferring B.V. Diclofenac formulations
US9855234B2 (en) * 2014-07-08 2018-01-02 Insys Development Company, Inc. Diclofenac sublingual spray
US11020356B2 (en) 2016-12-28 2021-06-01 Hisamitsu Pharmaceutical Co., Inc. Drug-containing patch
US20190374481A1 (en) * 2017-01-31 2019-12-12 Teikoku Seiyaku Co., Ltd. Administration regimen for a pharmaceutical patch comprising lidocaine and diclofenac
AU2018231842B2 (en) * 2017-03-07 2024-03-21 LYOTROPIC DELIVERY SYSTEMS Ltd Topical delivery systems for active compounds
KR20190101140A (ko) * 2018-02-22 2019-08-30 동아제약 주식회사 비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물
CN111867574B (zh) 2018-02-27 2023-08-04 久光制药株式会社 含有双氯芬酸的乳化凝胶组合物
US20210386858A1 (en) * 2019-02-19 2021-12-16 Bluepharma - Industria Farmacêutica, S.A. Mucoadhesive compositions and uses thereof
JP6744512B1 (ja) * 2020-02-12 2020-08-19 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
JP6761553B1 (ja) * 2020-02-12 2020-09-23 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
CA3169241A1 (en) 2020-02-27 2021-09-02 Dario N.R. CARRARA Topical diclofenac compositions and methods
JP2022096994A (ja) * 2020-12-18 2022-06-30 小林製薬株式会社 外用医薬組成物
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis
IT202100016751A1 (it) * 2021-06-25 2022-12-25 Altergon Sa Formulazione topica di diclofenac ad elevato tasso di assorbimento
KR20240067245A (ko) 2021-10-01 2024-05-16 뉴트리션 & 바이오사이언시즈 유에스에이 1, 엘엘씨 국소 적용을 위한 하이드로콜로이드 블렌드 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AR041021A1 (es) 2002-08-22 2005-04-27 Novartis Consumer Health Sa Composicion topica
US20040096569A1 (en) 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DK1670433T3 (da) * 2003-10-10 2012-03-12 Ferring Bv Transdermal farmaceutisk formulering til mindskelse af hudrester
US8158152B2 (en) 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
GB0524958D0 (en) 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents
ES2804472T3 (es) 2005-12-13 2021-02-08 Harvard College Estructuras para trasplante celular
TW200815045A (en) 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US8623401B2 (en) 2008-03-27 2014-01-07 Fenwafe Inc. Wafer formulation
AU2009319167A1 (en) * 2008-11-28 2010-06-03 Lectio Pharmaentwicklungs-Und Verwertungs Gmbh Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
US20120004306A1 (en) 2009-03-11 2012-01-05 Kowa Co., Ltd. External preparation containing analgesic/anti-inflammatory agent
NZ619857A (en) 2010-03-29 2015-05-29 Ferring Bv A fast dissolving pharmaceutical composition
AU2013289403B2 (en) * 2012-07-12 2017-05-11 Ferring B.V. Diclofenac formulations

Similar Documents

Publication Publication Date Title
JP2015522049A5 (cg-RX-API-DMAC7.html)
RU2014152445A (ru) Композиции на основе диклофенака
JP2014503565A5 (cg-RX-API-DMAC7.html)
AU2013359392C1 (en) Compositions and methods for tissue regeneration
WO2009053741A3 (en) Novel formulation
RU2013133082A (ru) Композиции тестостерона
ECSP045140A (es) Formulaciones farmacéuticas derivadas del platino
AR084691A1 (es) Formulacion de uso topico para un inhibidor de jak y metodo para tratar trastorno de la piel
JP2013515002A5 (cg-RX-API-DMAC7.html)
RU2015122627A (ru) Кожные композиции, содержащие неприродные гигроскопические аминокислоты
EA201590591A1 (ru) Способ приготовления геля на основе полифенолов гранатовой кожуры для лечения воспалительных заболеваний в гинекологии
US20140094438A1 (en) Compositions and methods for the treatment of pain
US9078869B2 (en) Method for treating skin inflammatory diseases
CN101455654A (zh) 精氨酸布洛芬凝胶剂及其制备方法
WO2024088153A1 (zh) 托品酸及其衍生物在制备治疗银屑病药物中的用途
CN101433544B (zh) 具有抗炎消肿镇痛作用的外用药物组合物制剂与用途
WO2017129108A1 (zh) 一种用于治疗皮肤病的硅凝胶
ITBS20120093A1 (it) Composizione cosmetica e/o farmaceutica per il trattamento dell'infiammazione della cute e delle sindromi correlate
NZ606177A (en) Compositions for the treatment of actinic keratosis
RU2016101152A (ru) Терапевтические агенты для применения в профилактике и/или лечении гиперкинетических двигательных расстройств
CN106456598A (zh) 外用药物组合物
CN112007039A (zh) 一种包含氟西汀和维生素d3或其衍生物的组合物,及其应用
JP6477005B2 (ja) 角層水分量の低下抑制剤
CN106413699B (zh) 外用药物组合物
CN101803961B (zh) 鱼用创可贴